GEM 21 NEUROPLEX Trademark

Trademark Overview


On Friday, August 25, 2017, a trademark application was filed for GEM 21 NEUROPLEX with the United States Patent and Trademark Office. The USPTO has given the GEM 21 NEUROPLEX trademark a serial number of 87584355. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 16, 2024. This trademark is owned by GEMINI BIOPRODUCTS, INC.. The GEM 21 NEUROPLEX trademark is filed in the Chemical Products category with the following description:

Media reagents for clinical or medical laboratory use and research use
gem 21 neuroplex

General Information


Serial Number87584355
Word MarkGEM 21 NEUROPLEX
Filing DateFriday, August 25, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 16, 2024
Registration Number5473957
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Pseudo MarkGEM TWENTY ONE NEUROPLEX
Goods and ServicesMedia reagents for clinical or medical laboratory use and research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, August 31, 2017
Primary Code001
First Use Anywhere DateMonday, February 22, 2010
First Use In Commerce DateWednesday, February 24, 2010

Trademark Owner History


Party NameGEMINI BIOPRODUCTS HOLDING, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWEST SACRAMENTO, CA 95605

Party NameGEMINI BIOPRODUCTS HOLDING, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWEST SACRAMENTO, CA 95605

Party NameGEMINI BIOPRODUCTS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Sacramento, CA 95605

Party NameGEMINI BIOPRODUCTS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Sacramento, CA 95605

Party NameGEMINI BIOPRODUCTS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Sacramento, CA 95605

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 30, 2017ASSIGNED TO EXAMINER
Monday, December 11, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, December 11, 2017EXAMINERS AMENDMENT E-MAILED
Monday, December 11, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 11, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, January 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 26, 2018ASSIGNED TO LIE
Wednesday, September 26, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 26, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 31, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Monday, August 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 16, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED